Gynecological Disorders

Learning Objectives

By the end of this page, you should be able to:

• Define endometriosis, PCOS, uterine fibroids, and abnormal uterine bleeding (AUB), and state their approximate prevalence
• Explain the pathophysiology behind endometriosis pain/infertility and the hormonal basis of PCOS
• List the Rotterdam criteria for diagnosing PCOS
• Differentiate the causes of AUB across age groups using the PALM-COEIN framework
• Choose an appropriate first-line investigation and management plan for each condition
• Distinguish gynecological conditions that are frequently confused with one another (e.g., fibroids vs. adenomyosis, PCOS vs. hypothyroidism)

Quick Answer

Gynecological disorders are conditions affecting the female reproductive tract that commonly present with pelvic pain, abnormal bleeding, or infertility. The four you must know cold for exams and clinical practice are endometriosis (ectopic endometrial tissue causing cyclical pain and infertility), PCOS (a hormonal-metabolic disorder causing irregular cycles, hyperandrogenism, and polycystic ovaries), uterine fibroids (benign myometrial tumors causing heavy bleeding and pressure symptoms), and abnormal uterine bleeding (a symptom, not a diagnosis, with causes classified by the PALM-COEIN system). Getting the diagnosis right matters because treatment ranges from watchful waiting to surgery, and misdiagnosis delays fertility treatment or misses malignancy.

Overview

These four conditions overlap heavily in how they present — irregular or heavy periods and pelvic pain — which is exactly why they are tested together and why students mix them up. The skill this page builds is pattern recognition: given a set of symptoms, age, and exam findings, which diagnosis fits best, and what is the next step?

Core Concepts

Endometriosis

Definition: Endometriosis is the presence of endometrial-like tissue (glands and stroma) outside the uterine cavity, most often on the ovaries, pelvic peritoneum, and uterosacral ligaments. It affects roughly 10% of women of reproductive age and up to 30-50% of women presenting with infertility.

Explanation: The leading theory is retrograde menstruation — menstrual blood flows backward through the fallopian tubes into the pelvis, where shed endometrial cells implant and respond to cyclical hormones just like the uterine lining does. This ectopic tissue bleeds with each cycle, triggering local inflammation, fibrosis, and adhesions. Adhesions distort pelvic anatomy, which explains both the pain (nerve irritation, traction on adhesions) and the infertility (tubal blockage, altered ovum pickup, chronic inflammation impairing implantation).

Example: A 28-year-old presents with dysmenorrhea that has progressively worsened over years, deep dyspareunia, and two years of unexplained infertility. Bimanual exam reveals a fixed, retroverted uterus and tender nodularity in the posterior fornix (uterosacral ligaments).

Real-World Example: Laparoscopy is both diagnostic (visualizing "powder-burn" or "gunshot" lesions, chocolate cysts on the ovary) and therapeutic (excision/ablation of implants) in the same procedure — this dual role is a favorite exam point.

Why It Matters: Endometriosis is one of the most common preventable causes of infertility investigated in gynecology clinics, and severity of pain does not correlate with the extent of disease seen at laparoscopy — a classic exam trap.

Common Misunderstanding: Students assume pelvic ultrasound reliably diagnoses endometriosis. It doesn't for peritoneal implants — ultrasound mainly detects endometriomas (ovarian cysts). Laparoscopy with biopsy remains the gold standard.

Symptoms: Cyclical pelvic pain worsening before/during menses, deep dyspareunia, dyschezia, infertility, occasionally cyclical hematuria/hematochezia if bladder/bowel involved.

Diagnosis: Laparoscopy with histological confirmation (gold standard); transvaginal ultrasound for endometriomas; CA-125 may be elevated but is nonspecific.

Treatment: NSAIDs for pain; combined oral contraceptives or progestins to suppress cycling; GnRH agonists for refractory disease; laparoscopic excision/ablation of implants; hysterectomy with bilateral salpingo-oophorectomy is the definitive but last-resort option in women who have completed childbearing.

Polycystic Ovary Syndrome (PCOS)

Definition: PCOS is a heterogeneous endocrine-metabolic disorder characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. It affects 5-10% of women of reproductive age and is the most common cause of anovulatory infertility.

Explanation: Insulin resistance is central to the pathophysiology in most patients: elevated insulin drives ovarian theca cells to overproduce androgens and lowers hepatic production of sex hormone-binding globulin (SHBG), which raises free testosterone further. High androgens disrupt normal follicular development, so follicles arrest at an early stage instead of ovulating — this is what produces the "string of pearls" appearance of small subcapsular follicles on ultrasound.

Example: A 22-year-old with 6-8 periods a year, new facial hair growth, and acne is found to have a fasting insulin level at the upper limit of normal and bilateral ovaries with more than 12 follicles each on ultrasound.

Real-World Example: The Rotterdam criteria (2 of 3 required) are the diagnostic backbone used worldwide: (1) oligo/anovulation, (2) clinical or biochemical hyperandrogenism, (3) polycystic ovaries on ultrasound — after excluding other causes like thyroid disease, hyperprolactinemia, and congenital adrenal hyperplasia.

Why It Matters: PCOS carries long-term metabolic risk — type 2 diabetes, dyslipidemia, and endometrial hyperplasia/cancer from unopposed estrogen due to chronic anovulation. Management is not just about periods and fertility; it's about metabolic surveillance for life.

Common Misunderstanding: Students think a woman needs visible ovarian cysts to be diagnosed with PCOS. In fact, a patient can meet Rotterdam criteria with normal-appearing ovaries if she has both anovulation and hyperandrogenism — the name is misleading.

Symptoms: Oligomenorrhea/amenorrhea, hirsutism, acne, androgenic alopecia, weight gain/difficulty losing weight, infertility.

Diagnosis: Clinical history + hyperandrogenism (clinical or serum free testosterone) + pelvic ultrasound; rule out thyroid dysfunction, prolactin excess, and 17-hydroxyprogesterone for CAH.

Treatment: Lifestyle modification (weight loss improves ovulation and insulin sensitivity) as first line; combined oral contraceptives for cycle regulation and hirsutism; metformin for insulin resistance; letrozole (preferred over clomiphene) for ovulation induction in those seeking pregnancy.

Uterine Fibroids (Leiomyomas)

Definition: Fibroids are benign, monoclonal smooth-muscle tumors of the myometrium, the most common pelvic tumor in women, with a lifetime incidence approaching 70-80% by age 50 (though most are asymptomatic).

Explanation: Fibroid growth is estrogen- and progesterone-dependent, which is why they grow during reproductive years and pregnancy and regress after menopause. They are classified by location — submucosal (bulge into the cavity, cause the heaviest bleeding and most infertility), intramural (within the muscle wall), and subserosal (project outward, cause bulk/pressure symptoms rather than bleeding).

Example: A 42-year-old reports progressively heavier periods requiring pad changes every hour, and a bimanual exam finds an enlarged, irregularly contoured, non-tender uterus.

Real-World Example: The FIGO classification system (types 0-8) is used clinically to describe fibroid location precisely, which determines whether hysteroscopic myomectomy (for submucosal types 0-2) is feasible or whether an abdominal/laparoscopic approach is needed.

Why It Matters: Fibroids are the most common indication for hysterectomy worldwide, but fertility-sparing options (myomectomy, uterine artery embolization) matter enormously for women who still want children — the exam expects you to match management to fertility goals, not default to hysterectomy.

Common Misunderstanding: Students assume all fibroids need treatment. Most are asymptomatic and require only surveillance; treatment is reserved for those causing bleeding, pain, pressure, or infertility.

Symptoms: Heavy/prolonged menstrual bleeding, pelvic pressure or pain, urinary frequency, constipation, occasionally infertility or recurrent miscarriage (submucosal type).

Diagnosis: Bimanual exam (enlarged, irregular, firm uterus), transvaginal ultrasound (first-line), MRI (best for mapping before surgery).

Treatment: Observation if asymptomatic; medical therapy (tranexamic acid, GnRH agonists/antagonists to shrink fibroids preoperatively); myomectomy (fertility-preserving); uterine artery embolization; hysterectomy for definitive treatment when childbearing is complete.

Abnormal Uterine Bleeding (AUB)

Definition: AUB is any deviation from a normal menstrual pattern in frequency, regularity, duration, or volume. It is a symptom, not a diagnosis — the job is always to find the underlying cause.

Explanation: The internationally accepted PALM-COEIN system splits causes into structural (PALM: Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia) and non-structural (COEIN: Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not otherwise classified). The most likely cause shifts predictably with age, which is the single most testable fact in this topic.

Example: A 16-year-old with heavy irregular bleeding since menarche most likely has anovulatory cycles from an immature hypothalamic-pituitary-ovarian axis, or a coagulopathy (von Willebrand disease) if bleeding is severe from menarche onward. A 55-year-old with postmenopausal bleeding must be assumed to have endometrial cancer until proven otherwise.

Real-World Example: Any woman over 45 (or younger with risk factors — obesity, PCOS, tamoxifen use) presenting with AUB needs an endometrial biopsy to exclude hyperplasia/malignancy before symptomatic treatment is started.

Why It Matters: Treating AUB symptomatically without identifying the cause can delay a cancer diagnosis — this is the highest-stakes reasoning error in gynecology exams and practice.

Common Misunderstanding: Students treat "AUB" as if it names a single disease. It's an umbrella symptom; the correct exam answer always requires identifying the PALM-COEIN category first.

Diagnosis: Pregnancy test first in any reproductive-age woman; pelvic ultrasound; endometrial biopsy if age >45 or risk factors present; coagulation studies in adolescents with severe bleeding.

Treatment: Address the underlying PALM-COEIN cause — hormonal therapy or tranexamic acid for ovulatory dysfunction, polypectomy/myomectomy for structural lesions, biopsy-directed management for hyperplasia.

Key Terms

Term	Definition
Endometrioma	An ovarian cyst filled with old, dark blood from ectopic endometrial tissue; called a "chocolate cyst"
Rotterdam criteria	Diagnostic criteria for PCOS requiring 2 of 3: anovulation, hyperandrogenism, polycystic ovaries on ultrasound
PALM-COEIN	FIGO classification system for causes of abnormal uterine bleeding (structural: Polyp, Adenomyosis, Leiomyoma, Malignancy; non-structural: Coagulopathy, Ovulatory, Endometrial, Iatrogenic, Not-classified)
Dyspareunia	Pain during sexual intercourse, a common symptom of endometriosis
Hirsutism	Excess terminal hair growth in a male pattern in women, a sign of hyperandrogenism seen in PCOS
Myomectomy	Surgical removal of fibroids while preserving the uterus, used when fertility is desired
Adenomyosis	Endometrial tissue growing within the myometrium (uterine muscle wall), often confused with fibroids
Postmenopausal bleeding	Any vaginal bleeding occurring 12+ months after the last menstrual period; considered endometrial cancer until excluded

Common Mistakes

Misconception 1: "Pain severity in endometriosis tells you how much disease is present." Why it's wrong: Pain intensity correlates poorly with the anatomical extent of implants seen at laparoscopy; some women with minimal disease have severe pain, and vice versa. Correct explanation: Diagnosis and staging require laparoscopic visualization/biopsy, not symptom severity alone.

Misconception 2: "PCOS requires visible cysts on ultrasound to diagnose." Why it's wrong: The Rotterdam criteria only need 2 of 3 features; a patient with anovulation and hyperandrogenism can be diagnosed with completely normal-looking ovaries. Correct explanation: PCOS is a clinical-biochemical diagnosis of exclusion; ultrasound findings are supportive, not mandatory.

Misconception 3: "All fibroids need surgical removal." Why it's wrong: Most fibroids are small, asymptomatic, and discovered incidentally; they regress after menopause as estrogen falls. Correct explanation: Treatment is reserved for fibroids causing symptomatic bleeding, pressure, pain, or infertility; asymptomatic fibroids are simply monitored.

Comparison and Connections

Feature	Endometriosis	Adenomyosis	Uterine Fibroids	PCOS
Tissue location	Ectopic tissue outside uterus (ovaries, peritoneum)	Endometrial tissue within myometrium	Benign smooth-muscle tumor within myometrium	Ovarian follicular arrest, hyperandrogenism
Typical patient	20s-30s, often infertile	Multiparous women 40s	Reproductive-age, especially African-descent women	Adolescent/young adult
Uterus on exam	Often normal size, fixed/retroverted	Diffusely enlarged, "boggy," tender	Irregularly enlarged, firm, non-tender	Normal size
Key symptom	Progressive dysmenorrhea, dyspareunia, infertility	Dysmenorrhea + menorrhagia	Heavy bleeding, pressure symptoms	Oligomenorrhea, hirsutism, acne
Gold-standard diagnosis	Laparoscopy + biopsy	MRI or histology post-hysterectomy	Ultrasound/MRI	Rotterdam clinical criteria
Definitive treatment	Excision or hysterectomy + BSO	Hysterectomy	Myomectomy or hysterectomy	Lifestyle change; no cure

Practice Questions

Recall

1. What are the three Rotterdam criteria for PCOS, and how many are needed for diagnosis? Answer guidance: Oligo/anovulation, clinical or biochemical hyperandrogenism, polycystic ovaries on ultrasound — 2 of 3 required, after excluding other causes.

2. What does the acronym PALM-COEIN stand for? Answer guidance: Structural — Polyp, Adenomyosis, Leiomyoma, Malignancy/hyperplasia; Non-structural — Coagulopathy, Ovulatory dysfunction, Endometrial, Iatrogenic, Not otherwise classified.

Understanding

3. Explain why endometriosis can cause infertility even when the fallopian tubes appear anatomically patent. Answer guidance: Chronic pelvic inflammation, altered peritoneal fluid composition, and impaired oocyte pickup/tubal motility can impair fertility independent of frank tubal blockage.

4. Why does insulin resistance worsen the clinical picture in PCOS beyond just metabolic risk? Answer guidance: Hyperinsulinemia stimulates ovarian theca cell androgen production and lowers hepatic SHBG, raising free testosterone and worsening hyperandrogenism and anovulation — a self-reinforcing cycle.

Application

5. A 46-year-old with new heavy irregular periods and a BMI of 34 comes to clinic. What is your first investigation and why? Answer guidance: Endometrial biopsy (after excluding pregnancy) because age >45 and obesity are risk factors for endometrial hyperplasia/cancer from unopposed estrogen — must exclude malignancy before symptomatic treatment.

6. A 30-year-old with known fibroids wants to conceive within the next year. Which fibroid location is most concerning for her fertility, and why? Answer guidance: Submucosal fibroids, because they distort the endometrial cavity and are most strongly associated with implantation failure and infertility; hysteroscopic myomectomy is often recommended.

Analysis

7. Compare and contrast how you would distinguish fibroids from adenomyosis in a 44-year-old with heavy menstrual bleeding, using exam findings and imaging. Answer guidance: Fibroids typically produce an irregularly, asymmetrically enlarged firm uterus with discrete masses visible on ultrasound/MRI; adenomyosis produces a diffusely enlarged, globular, tender ("boggy") uterus with poorly defined myometrial-endometrial junction on MRI. Fibroids are discrete tumors; adenomyosis is diffuse infiltration.

8. A student says "since this patient's pain doesn't sound that bad, she probably doesn't have severe endometriosis, so laparoscopy isn't needed." Evaluate this reasoning. Answer guidance: Flawed — pain severity does not correlate with disease extent at laparoscopy. If clinical suspicion exists (infertility, cyclical pain, dyspareunia) and empirical medical therapy fails or fertility is a concern, laparoscopy remains indicated regardless of reported pain severity.

FAQ

1. Can you have PCOS without being overweight? Yes. Roughly 20-30% of women with PCOS are lean. Insulin resistance can occur even at normal BMI, and hyperandrogenism/anovulation can be present independent of weight.

2. Does endometriosis always cause infertility? No. Many women with endometriosis conceive without difficulty; the risk of infertility rises with disease severity, but even minimal disease is associated with some reduction in fertility rates.

3. Do fibroids turn into cancer? Almost never. Malignant transformation to leiomyosarcoma is extremely rare (well under 1%). Rapid growth, especially after menopause, warrants further workup, but fibroids themselves are benign.

4. Is postmenopausal bleeding always serious? It must always be investigated urgently, but the most common cause is actually benign endometrial atrophy, not cancer. Still, endometrial cancer must be excluded first with biopsy because early diagnosis is curable.

5. Can lifestyle changes alone treat PCOS? Weight loss of even 5-10% can restore ovulation and improve insulin sensitivity in many women, making it genuinely first-line therapy — not just an adjunct — for overweight patients with PCOS.

Quick Revision

• Endometriosis = ectopic endometrial tissue outside the uterus; ~10% prevalence; gold standard diagnosis is laparoscopy + biopsy.
• Pain severity in endometriosis does NOT correlate with disease extent.
• PCOS diagnosed by Rotterdam criteria: 2 of 3 of anovulation, hyperandrogenism, polycystic ovaries — after excluding thyroid disease, hyperprolactinemia, CAH.
• PCOS carries long-term risk of type 2 diabetes and endometrial hyperplasia from unopposed estrogen.
• Fibroids (leiomyomas) are the most common benign pelvic tumor; estrogen/progesterone-dependent; classified by FIGO location (submucosal, intramural, subserosal).
• Submucosal fibroids cause the heaviest bleeding and most fertility impact.
• AUB is a symptom, not a diagnosis — always classify using PALM-COEIN.
• Postmenopausal bleeding = endometrial cancer until proven otherwise; biopsy is mandatory.
• Age >45 or risk factors (obesity, PCOS) + AUB = endometrial biopsy before symptomatic treatment.
• Adenomyosis vs. fibroids: diffuse boggy uterus vs. discrete irregular masses.
• Letrozole is now preferred over clomiphene for ovulation induction in PCOS.
• Most fibroids are asymptomatic and need only surveillance, not treatment.

Related Topics

Prerequisites:

• Normal menstrual cycle physiology and the hypothalamic-pituitary-ovarian axis
• Basic pelvic anatomy of the uterus, ovaries, and adnexa

Related Topics:

• Infertility evaluation and management
• Endometrial hyperplasia and endometrial cancer
• Menopause and hormone replacement therapy

Next Topics:

• Gynecological malignancies (cervical, ovarian, endometrial cancer)
• Contraception and hormonal therapy options